1Araiz JJ;Refojo MF;Arroyo MH.Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy,1993.
2Brown EJ,Albers MW,Shin TB,et al.A mammalian protein targeted by G1-arresting rapamycin-receptor complexNature,1994.
3Kwon YS,Hong HS,Kim JC,Shin JS,Son Y.Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo. Investigative ophthalmology&visual science . 2005
4Dos D Sarbassov,Siraj M Ali,Do-Hyung Kim,David A Guertin,Robert R Latek,Hediye Erdjument-Bromage,Paul Tempst,David M Sabatini.Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Current Biology . 2004
6RD Rao,JC Buckner,JN Sarkaria.Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents. Current Cancer Drug Targets . 2004
7Campochiaro PA.Pathogenesis of Proliferative Vitreoretinopathy. Retina . 2001
8Eibl KH,Kook D,Priglinger S,Haritoglou C,Yu A,Kampik A,et al.Inhibition of human retinal pigment epithelial cell attach-ment,spreading,and migration by alkylphosphocholines. In-vest Ophthalm ol Vis Sci . 2006
9Schalm SS,Fingar DC,Sabatini DM,Blenis J.TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Current Biology . 2003
10Lee JJ,Park JK,Kim YT,Kwon BM,Kang SG,Yoo YD,Yu YS,Chung H.Effect of 2-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model. Investigative Ophthalmology . 2002
